The targeting construct inserted a floxed neomycin resistance cassette inserted downstream of the C beta2 exon and modified the first Runx1-binding site within the Ebeta enhancer (TGTGGTT to TGCCACA) and the third Runx1-binding site within the Ebeta enhancer (TGCCACA to TTGGACA). (J:274549)